Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
National Institutes of Health Clinical Center (CC)
BioNTech SE
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
OncoC4, Inc.
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Imugene Limited
AstraZeneca
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
University of Florida
DualityBio Inc.
Big Ten Cancer Research Consortium
Genfit
State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital
RenJi Hospital
City of Hope Medical Center
Actym Therapeutics, Inc.
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC
Minia University
Elicio Therapeutics
University of Colorado, Denver
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Leap Therapeutics, Inc.
Region Stockholm
Oslo University Hospital
University Hospital, Ghent
Shanghai Bao Pharmaceuticals Co., Ltd.
Shandong Cancer Hospital and Institute
First Affiliated Hospital of Zhejiang University
Lisata Therapeutics, Inc.
Pfizer